Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Research

Future innovations in health care and prevention require research across a full spectrum of biomedical science, from basic and translational research to implementation science and comparative effectiveness research. 

AAMC advocates for funding and appropriate regulation by major federal agencies and organizations supporting this research, including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Department of Veterans Affairs (VA).

Ensuring a sustainable research mission is essential to achieve long-term health priorities, develop new therapeutics and preventive measures, focus on patient-centered outcomes, and reduce health disparities. 

We also work to ensure the integrity of biomedical research, especially research involving human subjects, including privacy protections and management of financial conflicts of interest.

Related

Responsible Conduct of Research
Research with AnimalsStem Cell Research and Regenerative Medicine

News and Updates


FDA Commissioner Gottlieb and NIH Director Collins Discuss the Promise of Regenerative Medicine

December 7, 2017

The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) hosted the Regenerative Medicine Innovation Workshop on Dec. 6-7, 2017, in Rockville, MD.  The workshop explored the field of regenerative medicine using adult stem cells and approaches to advance clinical research while ensuring interventions are safe and effective.


NIH and FDA Leaders Update House Committee on 21st Century Cures Act Implementation

December 1, 2017

The House Energy and Commerce Health Subcommittee Nov. 30 held a hearing titled, “Implementing the 21st Century Cures Act: An Update from FDA and NIH.”


Research Groups Oppose Proposed Prohibition on VA Research with Canines

December 1, 2017

The AAMC Nov. 17 joined a community letter, coordinated by the National Association for Biomedical Research, to House and Senate Appropriations Committee Chairs in opposition to the Preventing Unkind and Painful Procedures and Experiments on Respected Species Act (PUPPERS Act, H.R. 3197) and other efforts to defund research with canines at the U.S. Department of Veterans Affairs.


Senate HELP Committee Hearing on Gene Technology: Innovation and Impact

November 17, 2017

—Three research and industry institutions Nov. 14 testified before the Senate Health, Education, Labor, and Pensions (HELP) Committee about the role of gene editing technology, particularly CRISPR/Cas9, in developing treatments for genetic disorders as well as other uses.


Associations Object to EPA Policy Excluding Funded Scientists from Advisory Committees

November 10, 2017

The AAMC and four other higher education associations Nov. 6 sent a letter to Environmental Protection Agency (EPA) Administrator Scott Pruitt opposing a new policy to exclude EPA-grant funded scientists from the agency’s advisory committees.


On Government Affairs


Research Spectrum

Testimony and Correspondence